researchers have developed a new artificial intelligence-based software which may identify and measure the severity of common causes of strokes and
.
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk
.
originally published on may 17, 2018 10:46 pm
., and bones, and it�s not clear how the drugs will affect them after long-term use.
.